Purchase Order HHSD2002017M93711P
- Not listed
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Promega Corporation, a global life sciences company, for the MAXWELL(R) RSC VIRAL TNA product. The $76,649.40 firm fixed-price purchase order does not have a set-aside designation. Promega is a major supplier of specialized laboratory equipment and consumables to federal agencies, including the National Institutes of Health (NIH), Department of Defense (DoD), and Federal Bureau of Investigation...
- This federal contract award to Promega Corporation by the Department of Health and Human Services Centers for Disease Control and Prevention is a $139,908 firm fixed-price purchase order for TRL PROMEGA MAXWELL equipment and supplies. The award has no set-aside designation and was issued under the Coronavirus COVID-19 National Interest Action code, likely supporting COVID-19 research and testing efforts. Promega is a global life sciences company that provides DNA analysis equipment, reagents,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Promega Corporation, a large for-profit manufacturer of biological research and diagnostic products. The $89,600.84 contract is for the MAXWELL RSC SYSTEM AGREEMENT, which does not have a set-aside designation. Promega is a prime contractor that provides specialized laboratory equipment and consumables, such as DNA analysis systems, extraction instruments, and assay kits, to support...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Promega Corporation for $142,450.00 to provide laboratory supplies. The contract, which does not have a set-aside designation, will run through September 30, 2017. Promega, a global life sciences company that manufactures and markets integrated systems and reagents for biological research and molecular diagnostics, has previously provided DNA analysis equipment,...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Promega Corporation, a global life sciences company that manufactures laboratory equipment and reagents. The $138,722.80 firm fixed price purchase order is for a Maxwell CSC 48 Instrument, which will be used to ensure safe drinking water for research animals and minimize variables during animal studies. The contract represents a sole source award to Promega, as the...
- This $87,200 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract is for the supply of various laboratory equipment, reagents, and services to support the CDC's research and testing programs. It does not utilize a set-aside designation. Promega has several significant federal contract vehicles, including an $11.5 million...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $116,480.00 firm fixed price purchase order to Promega Corporation for the delivery of lab equipment. This award was not set aside for a specific business type. Promega Corporation is a global life sciences company that provides DNA analysis equipment, reagents, assays, and related laboratory supplies to support biomedical research and testing programs across federal agencies including the National...
- The Centers for Disease Control and Prevention (CDC) awarded a $49,465 purchase order to Promega Corporation for the delivery of MAXWELL (R) RSC 48 SYSTEM equipment. As part of its efforts to combat disease, the CDC's Pittsburgh office will utilize the molecular diagnostic products supplied under this firm fixed price contract running from September 21, 2023 through October 30, 2023. No subcontractors or set aside designations were specified. Promega will provide the equipment to support the...
- This is a firm fixed-price purchase order contract awarded by the Veterinary Services agency, a civilian agency within the U.S. government, to Promega Corporation for $18,435.60. The contract is for annual preventative maintenance of Promega's Maxwell RSC 48 equipment for end user Kiera Stewart. The contract does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical research and...
- This $7,684.50 firm fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the civilian Southeast Area division of the federal agency. The contract is for the supply of Catalog #AS1280 MAXWELL-16 LEV SIMPLYRNA TISSUE KIT, 48 PREPS. Promega is a large business and there was no set-aside designation for this award. In addition to this specific contract, Promega holds three significant federal indefinite delivery vehicle (IDV) contracts: a $10 million...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Promega Corporation, a global life sciences company, for a maintenance agreement for MAXWELL INSTRUMENTS. The potential value of the contract is $101,706.40 and the completion date is June 30, 2022. Promega has provided DNA analysis equipment, reagents, assays, and related laboratory supplies to support biomedical research and testing programs across various federal agencies, including the CDC, National Institutes of Health (NIH), Department of Defense (DoD), and Federal Bureau of Investigation (FBI). Promega currently holds two active indefinite delivery vehicle contracts with the NIH and Defense Health Agency for biological materials and DNA analysis systems, respectively. This award does not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Supplemental Agreement for work within scope | $0 | 3/8/23 | |
| 3 | Exercise an Option | $20.3k | 5/4/20 | |
| 2 | Exercise an Option | $20.3k | 2/26/19 | |
| 1 | Exercise an Option | $20.3k | 4/24/18 | |
| Not listed | Not listed | $20.3k | 4/27/17 |